--- title: "Chinese drugmaker WuXi AppTec faces a December investor exodus as US restrictions tighten." description: "On 28 October, the US Department of Homeland Security banned imports from BGI Genomics, MGI Tech and BGI Group under forced-labour rules. Washington had already listed Chinese pharmaceuticals Novogene" url: "https://bilby.ai/predictions/p/198/chinese-drugmaker-wuxi-apptec-faces-a-december-investor-exodus-as-us-restriction" markdown: "https://bilby.ai/predictions/p/198/chinese-drugmaker-wuxi-apptec-faces-a-december-investor-exodus-as-us-restriction.md" index: "https://bilby.ai/llms.txt" --- > For agents: Bilby answers questions about what governments do, from documents collected at source and checked by research analysts. To ask Bilby yourself, connect to its MCP server at https://pulse.bilby.ai/mcp (setup: https://docs.bilby.ai/developers/mcp-server). Every page on this site is also markdown: add .md to its address, or send Accept: text/markdown. https://bilby.ai/llms.txt lists them all. # Chinese drugmaker WuXi AppTec faces a December investor exodus as US restrictions tighten. - **Made:** 30 Oct 2026 - **By:** Owen Bae - **Market:** China - **Outcome:** Unresolved On 28 October, the US Department of Homeland Security banned imports from BGI Genomics, MGI Tech and BGI Group under forced-labour rules. Washington had already listed Chinese pharmaceuticals Novogene and WuXi as Chinese military companies in June, extending its crackdown across gene sequencing and drug manufacturing. A court suspended WuXi’s Pentagon designation in August, but the White House budget office can still list it separately. The next threat comes on 18 December, when the White House budget office must publish its list of “biotechnology companies of concern”. A listing would prevent federal agencies from buying from or funding companies that use WuXi’s services. WuXi is particularly exposed because US customers accounted for 77% of its US$4.28 billion revenue in the first half of 2026. Peer competitors Samsung Biologics and Lonza are poised to benefit from the fallout. ![Scenario tree for WuXi AppTec investor exits under tighter US restrictions](https://cms.bilby.ai/api/media/file/adt-2026-10-30-prediction-198.png?prefix=cms-media) [Ask Bilby about this prediction](https://pulse.bilby.ai/?prompt=Chinese%20drugmaker%20WuXi%20AppTec%20faces%20a%20December%20investor%20exodus%20as%20US%20restrictions%20tighten.) ## Ask Bilby about it Carry the prediction into a question: what has changed since, who decides, and who is exposed. - [What has changed since it was made?](https://pulse.bilby.ai/?prompt=What%20has%20changed%20since%20Bilby%20predicted%20this%3F%20Chinese%20drugmaker%20WuXi%20AppTec%20faces%20a%20December%20investor%20exodus%20as%20US%20restrictions%20tighten.) - [Who decides whether it happens?](https://pulse.bilby.ai/?prompt=Who%20decides%20whether%20this%20happens%3F%20Chinese%20drugmaker%20WuXi%20AppTec%20faces%20a%20December%20investor%20exodus%20as%20US%20restrictions%20tighten.) - [Who gains and who loses if it does?](https://pulse.bilby.ai/?prompt=Who%20gains%20and%20who%20loses%20if%20this%20happens%3F%20Chinese%20drugmaker%20WuXi%20AppTec%20faces%20a%20December%20investor%20exodus%20as%20US%20restrictions%20tighten.) ## More from China 37 predictions on China so far, newest first. - 9 Nov 2026 · [Costly winter gas purchases will push CPC’s accumulated losses to about NT$127.6 billion by the end of 2026](https://bilby.ai/predictions/p/209/costly-winter-gas-purchases-will-push-cpc-s-accumulated-losses-to-about-nt-127-6) · Unresolved - 6 Nov 2026 · [Nvidia is likely to win additional computing orders by the end of 2027.](https://bilby.ai/predictions/p/208/nvidia-is-likely-to-win-additional-computing-orders-by-the-end-of-2027) · Unresolved - 5 Nov 2026 · [China’s IPO restrictions will redirect billions of yuan towards private financing.](https://bilby.ai/predictions/p/205/china-s-ipo-restrictions-will-redirect-billions-of-yuan-towards-private-financin) · Unresolved [All 37 from China](https://bilby.ai/predictions/log?tag=china) · Marked true or false when each resolves ## See what we’re seeing next. New predictions in the Asia Daily Take, free every weekday, and in Bilby whenever you have a question. [Get the Asia Daily Take](https://bilby.ai/asia#asia-daily-take) · [Try Bilby](https://pulse.bilby.ai/sign-up)